- Regulatory Status
- RUO
- Other Names
- Protein Synthesis Inhibitor, Puromycin 2HCl, C22H31Cl2N7O5
- Ave. Rating
- Submit a Review
- Product Citations
- publications
-
Flow Cytometric Analysis of Intracellular Puromycin in Cells Treated with Inhibitors. Human PBMCs were stimulated with immobilized Ultra-LEAF™ Purified anti-human CD3 (clone UCHT1) (Cat. No. 300437) and Ultra-LEAF™ purified CD28 (clone CD28.2) (Cat. No. 302933) for 24 hours before being treated with 10 mM 2-Deoxy-D-Glucose (2-DG), 1 µM Oligomycin (O) or a combination of both (DGO) for 30 minutes at 37°C. Control cells were left untreated while test samples were treated with Puromycin (10 µg/mL) for 15 minutes. Cells were pelleted and resuspended in Cyto-Fast™ Fix/Perm Solution (Cat. No. 426803). After 30 minutes, cells were washed in Cyto-Fast™ Perm Wash Solution and intracellularly stained with PE anti-Puromycin (Cat. No. 381503). PE-fluorescence was analyzed by flow cytometry and the relative fluorescence was calculated by normalizing the mean fluorescence intensity of inhibitor-treated cells to vehicle-treated cells (Control). Error bars represent standard deviation from 3 different donors. -
HeLa cells were treated with Puromycin (10 µg/mL) for 2 hours and fixed with Fixation Buffer (Cat. No. 420801) for 30 minutes, permeabilized with 0.5% Triton X-100 for 15 minutes, and blocked with 5% FBS for 30 minutes. Cells were then intracellularly stained with 2.5 µg/mL Purified anti-Puromycin (clone 2A4) (Cat. No. 381502) overnight at 4°C followed by Alexa Fluor® 555 Goat anti-mouse IgG (red) (Cat. No. 405324) for one hour at room temperature. Nuclei were counterstained with DAPI (blue) (Cat. No. 422801). Scale bar: 20 µm
| Cat # | Size | Price | Quantity Check Availability | Save | ||
|---|---|---|---|---|---|---|
| 427508 | 50 mg | 120€ | ||||
Puromycin dihydrochloride is a naturally occurring amino nucleoside antibiotic produced by Streptomyces alboniger. Comprised of a nucleoside covalently bound to an amino acid, Puromycin mimics the 3′ end of aminoacylated tRNAs and thus inhibits protein synthesis by ribosome-catalyzed incorporation into elongating nascent chains, which results in premature termination of translation. It is used as a selection agent in mammalian cell cultures for cell lines that express a puromycin resistance via puromycin N-acetyl-transferase (pac).
Puromycin immunodetection with antibodies such as BioLegend’s clone 2A4 allows the direct evaluation of translational activity in single cells by immunofluorescence microscopy and flow cytometry.
Product Details
- Formulation
- Lyophilized
- Preparation
- Solubility: 50-100 mg/mL in distilled deionized water, PBS or DMSO.
- Storage & Handling
- Store lyophilized powder at -20°C. When reconstituted, aliquot and store at -20°C. Use reconstituted material within 6 months to avoid loss of potency.
- Application
-
Cell Culture - Verified
- Recommended Usage
-
Working concentrations of Puromycin dihydrochloride for cell-based assays range from 0.2 – 10 μg/mL. It is recommended that the reagent be titrated for each experiment to determine optimal performance.
Antigen Details
- Structure
- C22 H29N7O5 · 2HCl. MW = 544.43 g/mol
- Function
- Protein synthesis inhibitor, antibiotic
- Antigen References
-
- Arguello R, et al. 2020. Cell Metabolism. 32:1063-1075.
- Nathans D, et al. 1964. PNAS.51:585-92.
- Miyamoto-Sato E, et al. 2000. Nucleic Acids Res. 28:1176-82.
- Schmidt EK, et al. 2009. Nat Methods. 6:275-7.
- Gene ID
- NA
Login / Register 



Follow Us